Generic name · Immunology / IL-12/23

Ustekinumab J-Code / HCPCS Code

In short

Ustekinumab is billed under HCPCS J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg. One billing unit is 1 mg.

J3357 covers the subcutaneous formulation. The intravenous formulation has a separate code (J3358). Ustekinumab biosimilars are listed under their own names.

J3357 code details

Reference

Code
J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mgMed-Code curated
Billing unit
1 mg
Same code in the directory
Stelara
Pharmacologic class
Interleukin-12 Antagonist; Interleukin-23 AntagonistFrom the FDA listings below
J-code category
Immunology / IL-12/23

FDA-listed products

Finished products whose name and route match this directory entry.

Products matching Ustekinumab in Med-Code's directory
ProductStrengthForm · routeLabelerProduct NDC
Pyzchivaustekinumab-ttweUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousCordavis Limited83457-651
Pyzchivaustekinumab-ttweUstekinumab 90 mg/mLInjection, SolutionSubcutaneousCordavis Limited83457-652
Selarsdiustekinumab-aeknUstekinumab 90 mg/mLInjection, SolutionSubcutaneousA-S Medication Solutions50090-7769
Steqeymaustekinumab-stbaUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousCELLTRION USA, Inc.72606-027
Steqeymaustekinumab-stbaUstekinumab 90 mg/mLInjection, SolutionSubcutaneousCELLTRION USA, Inc.72606-028
Steqeymaustekinumab-stbaUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousCELLTRION USA, Inc.72606-060
StelaraustekinumabUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousJanssen Biotech, Inc.57894-060
StelaraustekinumabUstekinumab 90 mg/mLInjection, SolutionSubcutaneousJanssen Biotech, Inc.57894-061
ustekinumabUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousJanssen Biotech, Inc.57894-440
ustekinumabUstekinumab 90 mg/mLInjection, SolutionSubcutaneousJanssen Biotech, Inc.57894-441
Starjemzaustekinumab-hmnyUstekinumab 45 mg/.5mLInjectionSubcutaneousHikma Pharmaceuticals USA Inc.0143-9168
Ustekinumab-TtweUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousQuallent Pharmaceuticals Health LLC82009-160
Ustekinumab-TtweUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousQuallent Pharmaceuticals Health LLC82009-161
Ustekinumab-TtweUstekinumab 90 mg/mLInjection, SolutionSubcutaneousQuallent Pharmaceuticals Health LLC82009-162
Starjemzaustekinumab-hmnyUstekinumab 45 mg/.5mLInjectionSubcutaneousHikma Pharmaceuticals USA Inc.0143-9169
Wezlanaustekinumab-auubUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousNuvaila Limited84612-055
Wezlanaustekinumab-auubUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousNuvaila Limited84612-076
Wezlanaustekinumab-auubUstekinumab 90 mg/mLInjection, SolutionSubcutaneousNuvaila Limited84612-089
Starjemzaustekinumab-hmnyUstekinumab 90 mg/mLInjectionSubcutaneousHikma Pharmaceuticals USA Inc.0143-9170
Wezlanaustekinumab-auubUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousNuvaila Limited84612-855
Wezlanaustekinumab-auubUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousNuvaila Limited84612-876
Wezlanaustekinumab-auubUstekinumab 90 mg/mLInjection, SolutionSubcutaneousNuvaila Limited84612-889
Otulfiustekinumab-aauzUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousFresenius Kabi USA, LLC65219-822
Otulfiustekinumab-aauzUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousFresenius Kabi USA, LLC65219-824
Otulfiustekinumab-aauzUstekinumab 90 mg/mLInjection, SolutionSubcutaneousFresenius Kabi USA, LLC65219-826
Ustekinumab-AauzUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousFresenius Kabi USA, LLC65219-862
Ustekinumab-AauzUstekinumab 90 mg/mLInjection, SolutionSubcutaneousFresenius Kabi USA, LLC65219-866
YesintekustekinumabUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousBiocon Biologics Inc.83257-023
YesintekustekinumabUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneousBiocon Biologics Inc.83257-024
YesintekustekinumabUstekinumab 90 mg/mLInjection, SolutionSubcutaneousBiocon Biologics Inc.83257-025

Other products with this name

Same name but a different route, formulation or combination — the code above does not apply to these.

Other products named Ustekinumab
ProductStrengthForm · routeLabelerProduct NDC
Imuldosaustekinumab-srlfUstekinumab-srlf 45 mg/.5mLInjectionSubcutaneousAccord BioPharma Inc.69448-017
Imuldosaustekinumab-srlfUstekinumab-srlf 90 mg/mLInjectionSubcutaneousAccord BioPharma Inc.69448-018
Imuldosaustekinumab-srlfUstekinumab-srlf 130 mg/26mLInjectionIntravenousAccord BioPharma Inc.69448-019
Steqeymaustekinumab-stbaUstekinumab 130 mg/26mLInjection, SolutionIntravenousCELLTRION USA, Inc.72606-029
StelaraustekinumabUstekinumab 130 mg/26mLSolutionIntravenousJanssen Biotech, Inc.57894-054
ustekinumabUstekinumab 130 mg/26mLSolutionIntravenousJanssen Biotech, Inc.57894-444
Ustekinumab-TtweUstekinumab 130 mg/26mLInjection, SolutionIntravenousQuallent Pharmaceuticals Health LLC82009-163
Wezlanaustekinumab-auubUstekinumab 130 mg/26mLInjection, SolutionIntravenousNuvaila Limited84612-066
Starjemzaustekinumab-hmnyUstekinumab 130 mg/26mLInjectionIntravenousHikma Pharmaceuticals USA Inc.0143-9171
Otulfiustekinumab-aauzUstekinumab 130 mg/26mLSolutionIntravenousFresenius Kabi USA, LLC65219-828
YesintekustekinumabUstekinumab 130 mg/26mLSolutionIntravenousBiocon Biologics Inc.83257-026
Pyzchivaustekinumab-ttweUstekinumab 130 mg/26mLInjection, SolutionIntravenousSANDOZ INC61314-654
Ustekinumab-aeknUstekinumab-aekn 45 mg/.5mLInjection, SolutionSubcutaneousTeva Pharmaceuticals USA, Inc.51759-413
Ustekinumab-aeknUstekinumab-aekn 90 mg/mLInjection, SolutionSubcutaneousTeva Pharmaceuticals USA, Inc.51759-414
Selarsdiustekinumab-aeknUstekinumab-aekn 45 mg/.5mLInjection, SolutionSubcutaneousTeva Pharmaceuticals USA, Inc.51759-505
Selarsdiustekinumab-aeknUstekinumab-aekn 90 mg/mLInjection, SolutionSubcutaneousTeva Pharmaceuticals USA, Inc.51759-607
Selarsdiustekinumab-aeknUstekinumab-aekn 130 mg/26mLInjection, SolutionIntravenousTeva Pharmaceuticals USA, Inc.51759-708
Ustekinumab-aeknUstekinumab-aekn 45 mg/.5mLInjection, SolutionSubcutaneousTeva Pharmaceuticals USA, Inc.51759-709
Ustekinumab-aeknUstekinumab-aekn 90 mg/mLInjection, SolutionSubcutaneousTeva Pharmaceuticals USA, Inc.51759-710

Related

Med-Code uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in